Developing therapeutics to eliminate disease-driving cells.
#Oncology / Cell elimination therapeutics
Developed proprietary AAV vector platforms to deliver larger coding sequences; clinical programs in inherited retinal diseases.
#Gene therapy
Focused on therapies that harness the innate immune system.
#Immunology / Innate immunity
Expanding therapeutic potential of gene therapy.
#Gene therapy / AAV expansion
Described as 'Enhanced pairing. Unlocking potential.'
#Protein pairing / Biological tools
Developing Positive Functional Modulators to restore ABC transporter function; multiple recent translational and preclinical data disclosures (2024–2025).
#Genetic diseases / Precision therapeutics
Developing in vivo cell-specific gene delivery platform; regulatory progression and first-in-human dosing reported in 2024–2025.
#Gene therapy / in vivo cell-specific delivery
Focused on gene therapy approaches for cardiovascular disease.
#Cardiovascular gene therapy
Developing engineered B cells as a new category of cellular medicines.
#Cell therapy / Engineered B cells
Uses single-cell genomics to identify immune cell biology in tumors; launched with a $39M Series A led by Longwood and others.
#Oncology / Single-cell genomics-driven immunotherapy
Developing antibodies informed by tumor microenvironment biology.
#Immuno-oncology
Antibody therapeutics addressing serious unmet medical needs.
#Antibody therapeutics / Oncology
Developing conditionally activated immuno-stimulatory medicines (example: WTX-124 clinical activity referenced).
#Oncology / Immuno-stimulatory agents
Platform for identification of anti-tumor TCRs; Longwood co-founded and provided financing (~$48M across two rounds).
#T cell therapeutics / Immuno-oncology
Platform addressing bottlenecks in next-generation sequencing for translational research.
#Sequencing platform / Translational research tools
Manipulates metabolism to develop disease-modifying therapeutics.
#Metabolism-targeted therapeutics (immuno-oncology and immuno-inflammation)
Developing a new class of medicines for cancer and other diseases.
#Peptide-based therapeutics / Oncology & other diseases
Seeking to detect cancer early via blood-based technologies.
#Early cancer detection
Developing inhaled anti-infectives for life-threatening lung infections.
#Inhaled anti-infectives / Respiratory
Developing therapeutics that link gut microbiome and central nervous system to treat CNS diseases.
#Gut-brain axis therapeutics / CNS
Focused on treatments to ease burden of patients with severe endocrine disorders.
#Endocrine disorders
Bringing innovation to delivery of women's healthcare.
#Women's health / Delivery devices
Developing a new generation of small molecule protease inhibitors.
#Small molecule protease inhibitors
Dermatologist-recommended skin health cosmetics company.
#Dermatology / Skin health cosmetics
Developing oncology therapeutics that inhibit pathways critical to tumor growth and survival.
#Oncology / Small molecules
Leader in mitochondria-related drug discovery using innovative screening platform.
#Mitochondrial therapeutics / Aging-related diseases
Minimally invasive solutions for treatment of bone fractures.
#Minimally invasive orthopedic solutions
Developing therapies to improve meaningful outcomes for cancer patients; referenced in press approvals.
#Oncology therapeutics
Discovery, development, and commercialization of proprietary small-molecule drugs.
#Small-molecule drugs / Rare disease therapeutics
Focused on improving nutritional status and pill burden in patients with pancreatic diseases.
#Nutrition / Pancreatic disease supportive care